Collegium Pharmaceutical Revenue 2014-2020 | COLL

Collegium Pharmaceutical revenue from 2014 to 2020. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
Collegium Pharmaceutical Annual Revenue
(Millions of US $)
2019 $297
2018 $280
2017 $28
2016 $2
2015 $
2014 $
2013 $
Collegium Pharmaceutical Quarterly Revenue
(Millions of US $)
2020-06-30 $78
2020-03-31 $77
2019-12-31 $74
2019-09-30 $73
2019-06-30 $75
2019-03-31 $75
2018-12-31 $73
2018-09-30 $70
2018-06-30 $73
2018-03-31 $64
2017-12-31 $11
2017-09-30 $12
2017-06-30 $4
2017-03-31 $2
2016-12-31 $1
2016-09-30 $0
2016-06-30
2016-03-31
2015-12-31
2015-09-30
2015-06-30
2015-03-31
2014-12-31
2014-09-30
2014-06-30
2014-03-31
2013-12-31
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.648B $0.297B
Collegium Pharmaceutical Inc. is a specialty pharmaceutical company. It develops and commercializes prescription and over-the-counter pharmaceuticals for the treatment of central nervous system, respiratory and skin related disorders. The Company's product candidate consists of COL-195, COL-196, COL-171, COL-003 and COL-172 which are in different clinical trial. It developed a formulation platform technology, DETERx, for the treatment of chronic pain. Collegium Pharmaceutical Inc. is based in CUMBERLAND, United States.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $76.650B 43.60
Takeda Pharmaceutical (TAK) Japan $59.871B 10.43
Astellas Pharma (ALPMY) Japan $28.672B 14.53
Eisai (ESALY) Japan $27.225B 23.01
UCB SA (UCBJF) Belgium $22.660B 0.00
Merck (MKGAF) Germany $19.037B 24.97
Ono Pharmaceutical (OPHLF) Japan $15.737B 27.83
Catalent (CTLT) United States $13.837B 44.98
Grifols, S.A (GRFS) Spain $11.620B 14.20
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $11.140B 0.00
Neurocrine Biosciences (NBIX) United States $9.083B 35.16
IPSEN SA ADR (IPSEY) France $8.650B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $7.931B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $7.847B 12.98
STADA ARZNEIMI (STDAF) Germany $7.169B 0.00
Orion OYJ (ORINY) Finland $7.077B 24.56
Ionis Pharmaceuticals (IONS) United States $6.849B 43.39
United Therapeutics (UTHR) United States $4.508B 10.42
Arrowhead Pharmaceuticals (ARWR) United States $4.468B 0.00
Evotec AG (EVTCY) Germany $3.927B 136.32
FibroGen (FGEN) United States $3.886B 0.00
ChemoCentryx (CCXI) United States $3.686B 0.00
Hypermarcas (HYPMY) Brazil $3.281B 12.07
PTC Therapeutics (PTCT) United States $3.229B 0.00
Sage Therapeutics (SAGE) United States $3.113B 0.00
Nektar Therapeutics (NKTR) United States $3.013B 0.00
Pacira BioSciences (PCRX) United States $2.538B 66.71
Revolution Medicines (RVMD) United States $2.233B 0.00
Xencor (XNCR) United States $2.190B 0.00
Taro Pharmaceutical Industries (TARO) Israel $2.082B 10.08
Corcept Therapeutics (CORT) United States $2.004B 18.45
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.813B 0.00
Cronos Group (CRON) Canada $1.735B 0.00
USANA Health Sciences (USNA) United States $1.561B 14.70
Ironwood Pharmaceuticals (IRWD) United States $1.525B 10.59
Heron Therapeutics (HRTX) United States $1.383B 0.00
Trillium Therapeutics (TRIL) Canada $1.343B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.154B 11.00
Indivior (INVVY) United States $1.130B 14.00
Karyopharm Therapeutics (KPTI) United States $1.096B 0.00
Esperion Therapeutics (ESPR) United States $1.033B 0.00
Zogenix (ZGNX) United States $0.998B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.995B 0.00
CLINIGEN GP (CLIGF) United Kingdom $0.991B 0.00
Translate Bio (TBIO) United States $0.979B 0.00
Vectura Group (VEGPF) United Kingdom $0.894B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.886B 551.88
VAXART, INC (VXRT) United States $0.764B 0.00
Endo (ENDP) Ireland $0.735B 1.09
BioCryst Pharmaceuticals (BCRX) United States $0.648B 0.00
ImmunoGen (IMGN) United States $0.625B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.618B 0.00
Tilray (TLRY) Canada $0.613B 0.00
Calliditas Therapeutics AB (CALT) Sweden $0.575B 0.00
Siga Technologies (SIGA) United States $0.552B 58.92
Flexion Therapeutics (FLXN) United States $0.535B 0.00
Molecular Templates (MTEM) United States $0.524B 0.00
Aerie Pharmaceuticals (AERI) United States $0.513B 0.00
Radius Health (RDUS) United States $0.502B 0.00
Ocular Therapeutix (OCUL) United States $0.497B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.484B 0.00
Ardelyx (ARDX) United States $0.476B 0.00
Altimmune (ALT) United States $0.405B 0.00
Organogenesis Holdings (ORGO) United States $0.404B 0.00
Harpoon Therapeutics (HARP) United States $0.402B 0.00
TherapeuticsMD (TXMD) United States $0.402B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.390B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.386B 19.27
Redhill Biopharma (RDHL) Israel $0.352B 0.00
Akebia Therapeutics (AKBA) United States $0.350B 0.00
DURECT (DRRX) United States $0.349B 0.00
MEI Pharma (MEIP) United States $0.348B 0.00
PROFOUND MEDICL (PROF) Canada $0.337B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.327B 8.10
Innate Pharma SA (IPHYF) France $0.324B 0.00
IMV INC (IMV) Canada $0.298B 0.00
Jounce Therapeutics (JNCE) United States $0.278B 13.16
Concert Pharmaceuticals (CNCE) United States $0.277B 0.00
Xeris Pharmaceuticals (XERS) United States $0.266B 0.00
Menlo Therapeutics (VYNE) United States $0.263B 0.00
Rafael Holdings (RFL) United States $0.259B 0.00
Calithera Biosciences (CALA) United States $0.243B 0.00
Lannett Co Inc (LCI) United States $0.237B 5.50
KalVista Pharmaceuticals (KALV) United States $0.230B 0.00
Nature's Sunshine Products (NATR) United States $0.216B 21.31
Nivalis Therapeutics (ALPN) United States $0.202B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.197B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.194B 0.00
CASI Pharmaceuticals (CASI) United States $0.188B 0.00
Heat Biologics (HTBX) United States $0.186B 0.00
Otonomy (OTIC) United States $0.177B 0.00
OptiNose (OPTN) United States $0.170B 0.00
Taiwan Liposome (TLC) Taiwan $0.169B 0.00
Aquestive Therapeutics (AQST) United States $0.167B 0.00
Ayala Pharmaceuticals (AYLA) Israel $0.158B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.154B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.140B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.138B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.134B 0.00
Champions Oncology (CSBR) United States $0.117B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.111B 0.00
Aclaris Therapeutics (ACRS) United States $0.110B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.105B 0.00
MediWound (MDWD) Israel $0.101B 0.00
Lipocine (LPCN) United States $0.092B 0.00
Hemispherx BioPharma (AIM) United States $0.087B 0.00
Biomerica (BMRA) United States $0.083B 0.00
CTI BioPharma (CTIC) United States $0.077B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.075B 0.00
ElectroCore (ECOR) United States $0.073B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.072B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.072B 0.00
Novan (NOVN) United States $0.070B 0.00
Addex Therapeutics (ADXN) Switzerland $0.068B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.067B 0.00
Infinity Pharmaceuticals (INFI) United States $0.067B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.061B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.058B 0.00
Natural Alternatives (NAII) United States $0.052B 0.00
Recro Pharma (REPH) United States $0.051B 0.00
CV Sciences (CVSI) United States $0.051B 0.00
Onconova Therapeutics (ONTX) United States $0.050B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.050B 29.91
SCYNEXIS (SCYX) United States $0.048B 0.00
ProPhase Labs (PRPH) United States $0.044B 0.00
India Globalization Capital (IGC) United States $0.044B 0.00
Forward Pharma (FWP) Denmark $0.041B 0.00
PolarityTE (PTE) United States $0.040B 0.00
IsoRay (ISR) United States $0.039B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.035B 0.00
Mannatechorporated (MTEX) United States $0.035B 8.98
GTx (ONCT) United States $0.035B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.034B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.033B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.031B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.030B 0.00
AgeX Therapeutics (AGE) United States $0.030B 0.00
Neos Therapeutics (NEOS) United States $0.028B 0.00
Can-Fite Biopharma (CANF) Israel $0.027B 0.00
Jaguar Animal Health (JAGX) United States $0.025B 0.00
Vical (BBI) United States $0.023B 0.00
Midatech Pharma (MTP) United Kingdom $0.022B 0.00
Sundial Growers (SNDL) Canada $0.020B 0.00
Regulus Therapeutics (RGLS) United States $0.019B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.018B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.017B 0.00
HANCOCK JAFFE (HJLI) United States $0.017B 0.00
Flex Pharma (SLRX) United States $0.016B 0.00
Cyanotech (CYAN) United States $0.016B 23.41
Bio-Path Holdings (BPTH) United States $0.015B 0.00
Iterum Therapeutics (ITRM) Ireland $0.014B 0.00
RXi Pharmaceuticals (PHIO) United States $0.012B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.011B 0.00
JanOne (JAN) United States $0.009B 0.00
Shineco (TYHT) China $0.008B 0.00
China SXT Pharmaceuticals (SXTC) China $0.008B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
CannTrust Holdings (CTST) Canada $0.000B 0.00